[Not Available].
作者信息
Yoshida Winston Bonetti
机构信息
Universidade Estadual Paulista - UNESP, Faculdade de Medicina de Botucatu, Departamento de Cirurgia e Ortopedia, Botucatu, SP, Brasil.
出版信息
J Vasc Bras. 2017 Apr-Jun;16(2):85-87. doi: 10.1590/1677-5449.041017.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]。
J Vasc Bras. 2017 Apr-Jun;16(2):85-87. doi: 10.1590/1677-5449.041017.
引用本文的文献
1
Optimal Thromboprophylaxis in Laparoscopic Bariatric Surgery in a Private Third-Level Center in Mexico City.墨西哥城一家私立三级中心腹腔镜减肥手术的最佳血栓预防措施
Cureus. 2025 Jun 23;17(6):e86593. doi: 10.7759/cureus.86593. eCollection 2025 Jun.
本文引用的文献
1
Risk of thrombosis and thromboembolic prophylaxis in obesity surgery: data analysis from the German Bariatric Surgery Registry.肥胖手术中血栓形成和血栓栓塞预防的风险：来自德国肥胖手术登记处的数据分析
Obes Surg. 2016 Nov;26(11):2562-2571. doi: 10.1007/s11695-016-2182-4.
2
Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations.预防病态肥胖患者静脉血栓栓塞的化学预防：文献综述与给药建议。
J Thromb Thrombolysis. 2016 Apr;41(3):475-81. doi: 10.1007/s11239-015-1231-5.
3
The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.EFFORT试验：肥胖症手术患者预防血栓形成的术前依诺肝素与术后磺达肝癸钠对比：一项随机双盲试验
Surg Obes Relat Dis. 2015 May-Jun;11(3):672-83. doi: 10.1016/j.soard.2014.10.003. Epub 2014 Oct 23.
4
Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients.大剂量血栓预防对病态肥胖住院患者的疗效和安全性
Thromb Haemost. 2014 Jan;111(1):88-93. doi: 10.1160/TH13-01-0042. Epub 2013 Oct 17.
5
Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.非骨科手术患者静脉血栓栓塞症的预防：抗血栓治疗和血栓预防，第 9 版：美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e227S-e277S. doi: 10.1378/chest.11-2297.
6
Venous thromboembolism after laparoscopic bariatric surgery for morbid obesity: clinical burden and prevention.腹腔镜减重手术治疗病态肥胖后静脉血栓栓塞症：临床负担和预防。
Surg Obes Relat Dis. 2012 Jan-Feb;8(1):108-15. doi: 10.1016/j.soard.2011.09.005. Epub 2011 Sep 16.
7
Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery.两种低分子量肝素给药方案用于腹腔镜减肥手术患者的比较。
Surg Endosc. 2008 Nov;22(11):2392-5. doi: 10.1007/s00464-008-9997-6. Epub 2008 Jul 2.
8
Post discharge prophylactic anticoagulation in gastric bypass patient-how safe?胃旁路手术后患者出院后的预防性抗凝治疗——安全性如何？
Obes Surg. 2008 Jul;18(7):791-6. doi: 10.1007/s11695-007-9382-x. Epub 2008 Apr 3.
9
Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.依诺肝素在胃旁路手术患者中的血栓预防：延长疗程、剂量分层及抗Xa因子活性
Surg Obes Relat Dis. 2008 Sep-Oct;4(5):625-31. doi: 10.1016/j.soard.2007.11.010. Epub 2008 Feb 8.
10
Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study.依诺肝素用于肥胖症手术患者的血栓预防：接受依诺肝素的肥胖症手术患者预防静脉血栓栓塞结局的研究（PROBE研究）结果
Obes Surg. 2005 Nov-Dec;15(10):1368-74. doi: 10.1381/096089205774859245.
Zotero 插件